SESN2 and SESN3 suppress NK-92 cell-mediated cytotoxic activity on ovarian cancer cells through the induction of AMPK and inhibition of mTORC1, pointing at its potential relevance for immunotherapy in ovarian cancer [81]. This evidence concerns the gene SESN2 and ovarian cancer.